Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia [6]

Leukemia and Lymphoma

Volumn 48, Issue 6, 2007, Pages 1231-1233

  Ross, David M ^a   Jackson, Sharon R ^b   Browett, Peter J ^c  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTARABINE; HYDROXYUREA; IMATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BONE MARROW CELL; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; CYTOPENIA; DEATH; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE 46,XX; LETTER; LEUKOCYTE COUNT; MEGALOCYTOSIS; MONOSOMY 7; MYELODYSPLASIA; NEUTROPENIA; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT DURATION; TRISOMY 12; TRISOMY 8;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC, ATYPICAL, BCR-ABL NEGATIVE; LEUKEMIA, MYELOID, CHRONIC-PHASE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PIPERAZINES; PYRIMIDINES;

EID: 34347342753     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701297360     Document Type: Letter

References (15)

1. Fayad, L., Kantarjian, H., O'Brien, S., Seong, D., Albitar, M. and Keating, M. (1997) Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: Report of three cases. Leukemia, 11, pp. 767-771.
2. Ohtsuka, E., Kikuchi, H., Abe, Y., Moriyama, K., Ohno, E. and Hirota, K. (1995) Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome. Br J Haematol, 90, pp. 951-953.
3. Herens, C., Baron, F., Croisiau, C., Tassin, F. and Bours, V. (2003) Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases. Cancer Genet Cytogenet, 147, pp. 78-80.
4. Schoch, C., Haferlach, T., Kern, W., Schnittger, S., Berger, U. and Hehlmann, R. (2003) Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate. Leukemia, 17, pp. 461-463.
5. Chee, Y. L., Vickers, M. A., Stevenson, D., Holyoake, T. L. and Culligan, D. J. (2003) Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia, 17, pp. 634-635.
6. Medina, J., Kantarjian, H., Talpaz, M., O'Brien, S., Garcia-Manero, G. and Giles, F. (2003) Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Cancer, 98, pp. 1905-1911.
7. O'Dwyer, M. E., Gatter, K. M., Loriaux, M., Druker, B. J., Olson, S. B. and Magenis, R. E. (2003) Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate. Leukemia, 17, pp. 481-487.
8. Terre, C., Eclache, V., Rousselot, P., Imbert, M., Charrin, C. and Gervais, C. (2004) Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia. Leukemia, 18, pp. 1340-1346.
9. Cullen, M. J., Richards, S. J., Dickinson, H., Carter, C., Swirsky, D. M. and Owen, R. G. (2004) Development and progression of a Philadelphia-chromosome-negative acute myelocytic leukemia clone in a patient with Philadelphia-chromosome-positive chronic myelocytic leukemia. Cancer Genet Cytogenet, 148, pp. 170-173.
10. Bacher, U., Hochhaus, A., Berger, U., Hiddemann, W., Hehlmann, R. and Haferlach, T. (2005) Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia, 19, pp. 460-463.
11. Kovitz, C., Kantarjian, H., Garcia-Manero, G., Abruzzo, L. V. and Cortes, J. (2006) Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood, 108, pp. 2811-2813.
12. Ross, D. M., Branford, S., Moore, S. and Hughes, T. P. (2006) Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL. Leukemia, 20, pp. 664-670.
13. Lin, Y., Bruyere, H., Horsman, D. E., Pantzar, T., Barnett, M. J. and Hogge, D. E. (2006) Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: A report of nine cases and analysis of predictive factors. Cancer Genet Cytogenet, 170, pp. 16-23.
14. Roy, L., Guilhot, J., Martineau, G., Larchee, R. and Guilhot, F. (2005) Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia. Leukemia, 19, pp. 1689-1692.
15. Thiele, J., Kvasnicka, H. M., Schmitt-Graeff, A., Kriener, S., Engels, K. and Staib, P. (2005) Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: An immunohistochemical study on 75 patients. Histopathology, 46, pp. 540-550.